# Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen

> **NCT04454996** · PHASE4 · UNKNOWN · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 100 (estimated)

## Conditions studied

- Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome

## Interventions

- **DRUG:** tong-jiang granules
- **DRUG:** Chang 'an II Recipe
- **DRUG:** The placebo of tong-jiang granules
- **DRUG:** The placebo of Chang 'an II Recipe

## Key facts

- **NCT ID:** NCT04454996
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-25
- **Primary completion:** 2021-09-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04454996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04454996, "Study on the Rule and Mechanism of Treating Functional Gastrointestinal Diseases From the Perspective of Liver and Spleen". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04454996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*